Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 3.65% is 95% below its 5-year average of 76.33%, near the low end of its 5-year range (1.14%–211.49%).
As of the fiscal period ended Tuesday, June 30, 2026. 93.86% below its 12-month average of 59.45%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.65%.
DEBT TO ASSETS RATIO
3.65%
DEBT TO ASSETS RATIO AVG TTM
59.45%
DEBT TO ASSETS RATIO AVG 3Y
103.53%
DEBT TO ASSETS RATIO AVG 5Y
76.33%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-93.86%
CURRENT VS 3Y AVG
-96.48%
CURRENT VS 5Y AVG
-95.22%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+3952.82%
vs the sector median at left
NRx Pharmaceuticals, Inc.
Market Cap
$127.29M
Debt to Assets Ratio
3.65%
TTM Avg
59.45%
3Y Avg
103.53%
5Y Avg
76.33%
Market Cap
$127.98M
Debt to Assets Ratio
0.32%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$124.18M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$130.79M
Debt to Assets Ratio
0.47%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$131.21M
Debt to Assets Ratio
0.36%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$122.66M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NRx Pharmaceuticals, Inc. (NRXP) | $127.29M | 3.65% | 59.45% | 103.53% | 76.33% |
| Pyxis Oncology, Inc. (PYXS)vs › | $127.98M | 0.32% | N/A | N/A | N/A |
| Entera Bio Ltd. (ENTX)vs › | $124.70M | 0.02% | N/A | N/A | N/A |
| TuHURA Biosciences, Inc. (HURA)vs › | $124.18M | 0.01% | N/A | N/A | N/A |
| Health Catalyst, Inc. (HCAT)vs › | $130.79M | 0.47% | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $131.21M | 0.36% | N/A | N/A | N/A |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $122.66M | 0.01% | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $132.03M | 0.10% | N/A | N/A | N/A |
| BGM Group Ltd. (BGM)vs › | $122.43M | 0.00% | N/A | N/A | N/A |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
Debt/Assets
3.6%
Debt/Equity
N/A
Current Ratio
0.86
Interest Coverage
-24.2x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 3.65% |
| 2026-03-31 | 7.85% |
| 2025-12-31 | 4.87% |
| 2025-09-30 | 69.41% |
| 2025-06-30 | 211.49% |
| 2025-03-31 | 110.63% |
| 2024-12-31 | 180.14% |
| 2024-09-30 | 149.46% |
| 2024-06-30 | 163.26% |
| 2024-03-31 | 178.96% |
| 2023-12-31 | 125.24% |
| 2023-09-30 | 76.80% |
| 2023-06-30 | 64.07% |
| 2023-03-31 | 55.96% |
| 2022-12-31 | 40.77% |
| 2022-03-31 | 1.19% |
| 2021-12-31 | 1.58% |
| 2021-09-30 | 1.14% |
| 2021-06-30 | 3.70% |
| 2021-03-31 | 47.29% |
| 2020-12-31 | 27.10% |
| 2020-09-30 | 40.64% |
| 2020-06-30 | 37.49% |
| 2020-03-31 | 34.76% |
| 2019-12-31 | 6.09% |
| 2019-09-30 | 4.30% |
| 2019-06-30 | 3.17% |
| 2019-03-31 | 2.07% |
| 2018-12-31 | 0.97% |
| 2018-09-30 | 468.66% |
| 2018-06-30 | 293.24% |
| 2018-03-31 | 87.71% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 57.53% |
